Effect of melatonin on calyculin A-induced tau hyperphosphorylation

European Journal of Pharmacology

Volumn 510, Issue 1-2, 2005, Pages 25-30

  Li, Xia Chun ^a   Wang, Ze Fen ^a   Zhang, Jun Xia ^a   Wang, Qun ^a   Wang, Jian Zhi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alzheimer disease; Calyculin A; Melatonin; Phosphorylation; Tau

Indexed keywords

CALYCULIN A; GLYCOGEN SYNTHASE KINASE 3; MALONALDEHYDE; MELATONIN; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; TAU PROTEIN;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; INCUBATION TIME; MOUSE; NEUROBLASTOMA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 14644414141     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.01.023     Document Type: Article

References (32)

1. D. Acuna-Castroviejo, A. Coto-Montes, M.M. Gaia, G.G. Ortiz, and R.J. Reiter Melatonin is protective against MPTP-induced striatal and hippocampal lesions Life Sci. 60 1997 L23 L29
2. G. Benitez-King, I. Tunez, A. Bellon, G.G. Ortiz, and F. Anton-Tay Melatonin prevents cytoskeletal alterations and oxidative stress induced by okadaic acid in N1E-115 cells Exp. Neurol. 182 2003 151 159
3. N.Y. Calingasan, K. Uchida, and G.E. Gibson Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease J. Neurochem. 72 1999 751 756
4. B. Favre, P. Turowiski, and B.A. Hemmings Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin A, okadaic acid, and tautomycin J. Biol. Chem. 272 1997 13856 13863
5. M. Godert, M.G. Spillantini, and N.J. Cairns Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms Neuron 8 1992 159 168
6. A. Gomez-Ramos, J. Diaz-Nido, and M.A. Smith Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells J. Neurosci. Res. 71 2003 863 870
7. C.X. Gong, T.J. Singh, and I. Grundke-Iqbal Phosphoprotein phosphatase activities in Alzheimer disease brain J. Neurochem. 61 1993 921 927
8. I. Grundke-Iqbal, K. Iqbal, M. Quinlan, Y.C. Tung, M.S. Zaidi, and H.M. Wisniewski Microtubule-associated protein tau: a component of Alzheimer paired helical filaments J. Biol. Chem. 261 1986 6084 6089
9. H. Ishihara, B.L. Martin, D.L. Brautigan, H. Karaki, H. Ozaki, Y. Kato, N. Fusetani, S. Watabe, K. Hashimoto, and D. Uemura Calyculin A and okadaic acid: inhibitors of phosphatase activity Biochem. Biophys. Res. Commun. 159 1989 871 877
10. K. Kanemaru, K. Takio, R. Mirua, K. Titani, and Y. Ihara Fetal-type phosphorylation of the tau in paired helical filaments J. Neurochem. 60 1992 1667 1675
11. Y. Kato, N. Fusetani, and S. Matsunaga Calyculin A, a novel antitumour metabolite from the marine sponge Discodermia calyx J. Am. Chem. Soc. 108 1986 2780 2781
12. H. Kobe, A. Nakai, T. Koshino, and T. Araki Effect of regular maternal exercise on lipid peroxidation levels and antioxidant enzymatic activities before and after delivery J. Nippon Med. Sch. 69 2002 542 548
13. E. Kopke, Y.C. Tung, S. Shaikh, A.C. Alonso, K. Iqbal, and I. Grundke-Iqbal Microtubule associated protein tau: abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease J. Biol. Chem. 268 1993 24374 24384
14. V.M. Lee, B.J. Balin, L. Otvos Jr., and J.Q. Trojanowski A68: a major subunit of the paired helical filaments and derivatized forms of normal tau Science 251 1991 675 678
15. S.P. Li, Y.Q. Deng, X.C. Wang, Y.P. Wang, and J.Z. Wang Melatonin protects SH-SY5Y neuroblastoma cells from calyculin A-induced neurofilament impairment and neurotoxicity J. Pineal Res. 36 2004 186 191
16. S.J. Liu, and J.Z. Wang Alzheimer-like tau phosphorylation induced by wortmannin in vivo and its attenuation by melatonin Acta Pharmacol. Sin. 23 2002 183 187
17. W.R. Markesbery, and J.M. Carney Oxidative alterations in Alzheimer's disease Brain Pathol. 9 1999 133 146
18. S. Marklund, and G. Marklund Involvement of the superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase Eur. J. Biochem. 47 1974 469 474
19. P. Montilla-Lopez, M.C. Munoz-Agueda, L.M. Feijoo, J.R. Munoz-Castaneda, I. Bujalance-Arenas, and I. Tunez-Finana Comparison of melatonin versus vitamin C on oxidative stress and antioxienzyme activity in Alzheimer's disease induced by okadaic acid in neuroblastoma cells Eur. J. Pharmacol. 451 2002 237 243
20. M.A. Pappolla, M. Sos, and R.A. Omar Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide J. Neurosci. 17 1997 1683 1690
21. J.J. Pei, T. Tananka, Y.C. Tung, E. Braak, K. Iqbal, and I. Grundke-Iqbal Distribution, levels, and activity of glycogen synthase-3 in the Alzheimer's disease brain J. Neuropathol. Exp. Neurol. 56 1997 70 78
22. M. Perez, F. Hernandez, A. Gomez-Ramos, M. Smith, G. Perry, and J. Avila Formation of aberrant phosphotau fibrillar polymers in neural cultured cells Eur. J. Biochem. 269 2002 1484 1489
23. M.A. Smith, R.K. Kutty, and P.L. Richey Hemeoxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease Am. J. Pathol. 145 1994 42 47
24. M.A. Smith, C.A. Rottkamp, A. Nunomura, A.K. Raina, and G. Perry Oxidative stress in Alzheimer's disease Biochim. Biophys. Acta 1502 2000 139 144
25. E. Sontag, V. Nunbhakdi-Craig, G. Lee, R. Brandt, C. Kamibayashi, J. Kuret, C.L. White, M.C. Mumby, and G.S. Bloom Molecular interactions among protein phosphatase 2A, tau, and microtubules: implications for the regulation of tau phosphorylation and the development of tauopathies J. Biol. Chem. 274 1999 25490 25498
26. L. Sun, S.Y. Liu, X.W. Zhou, X.C. Wang, R. Liu, Q. Wang, and J.Z. Wang Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats Neuroscience 118 2003 1175 1182
27. I. Tsujio, T. Tanaka, T. Kudo, T. Nishikawa, K. Shinozaki, I. Grundke-Iqbal, K. Iqbal, and M. Takeda Inactivation of glycogen synthase kinase-3 by protein kinase C delta: implications for regulation of tau phosphorylation FEBS Lett. 469 2000 111 117
28. J.Z. Wang, I. Grundke-Iqbal, and K. Iqbal Restoration of biological activity of Alzheimer abnormally phosphorylated τ by dephosphorylation with protein phosphatase-2A, -2B and -1 Mol. Brain Res. 38 1996 200 208
29. D.L. Wang, Z.Q. Ling, F.Y. Cao, L.Q. Zhu, and J.Z. Wang Melatonin attenuates isoproterenol-induced protein kinase A overactivation and tau hyperphosphorylation in rat brain J. Pineal Res. 37 2004 11 16
30. H. Yamamoto, M. Hasegawa, T. Ono, K. Tashima, Y. Ihara, and E. Miyamoto Dephosphorylation of fetal-tau and paired helical filament-tau by protein phosphatase 1 and 2A and calcineurin J. Biochem. 118 1995 1224 1231
31. T. Yamamoto, K. Yuyama, K. Nakamura, T. Kato, and H. Yamamoto Kinetic characterization of the nitric oxide toxicity for pc12 cells: effect of half-life time of no release Eur. J. Pharmacol. 397 2000 25 33
32. X. Zhu, C.A. Rottkamp, H. Boux, A. Takeda, G. Perry, and M.A. Smith Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease J. Neuropathol. Exp. Neurol. 59 2000 880 888